Immunoinformatics prediction of linear epitopes from Taenia solium TSOL18.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3124692)

Published in Bioinformation on June 23, 2011

Authors

Mirko Zimic, Andrés Hazaet Gutiérrez, Robert Hugh Gilman, César López, Miguel Quiliano, Wilfredo Evangelista, Armando Gonzales, Héctor Hugo García, Patricia Sheen

Articles cited by this

A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65

UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47

Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol (2001) 66.87

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis (1997) 57.27

Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng (1997) 38.38

GROMACS: fast, flexible, and free. J Comput Chem (2005) 27.22

The HMMTOP transmembrane topology prediction server. Bioinformatics (2001) 12.57

Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. J Mol Biol (1992) 11.97

SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics (1998) 11.91

Enhanced genome annotation using structural profiles in the program 3D-PSSM. J Mol Biol (2000) 10.87

FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J Mol Biol (2001) 10.02

Protein identification and analysis tools in the ExPASy server. Methods Mol Biol (1999) 6.31

CAFASP-1: critical assessment of fully automated structure prediction methods. Proteins (1999) 5.54

Epitope landscape in breast and colorectal cancer. Cancer Res (2008) 5.29

Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science (1998) 3.68

Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins (2006) 3.15

The PredictProtein server. Nucleic Acids Res (2003) 2.72

Taenia solium cysticercosis. Infect Dis Clin North Am (2000) 2.39

ProPred1: prediction of promiscuous MHC Class-I binding sites. Bioinformatics (2003) 2.10

Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med (1995) 2.02

ASAView: database and tool for solvent accessibility representation in proteins. BMC Bioinformatics (2004) 1.94

Development and optimization of the FAST-ELISA for detecting antibodies to Schistosoma mansoni. J Immunol Methods (1986) 1.32

Vaccination of pigs to control human neurocysticercosis. Am J Trop Med Hyg (2005) 1.32

Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. Neurology (2002) 1.24

The key role of genomics in modern vaccine and drug design for emerging infectious diseases. PLoS Genet (2009) 1.18

Vaccination against cysticercosis and hydatid disease. Parasitol Today (2000) 1.17

Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol (2010) 1.15

Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis. J Clin Microbiol (2003) 1.11

Taenia solium oncosphere antigens induce immunity in pigs against experimental cysticercosis. Vet Parasitol (2002) 1.07

Molecular and genetic characterisation of the host-protective oncosphere antigens of taeniid cestode parasites. Int J Parasitol (2003) 1.04

Protection against hydatid disease induced with the EG95 vaccine is associated with conformational epitopes. Vaccine (2000) 1.02

Antibody responses and epitope specificities to the Taenia solium cysticercosis vaccines TSOL18 and TSOL45-1A. Parasite Immunol (2006) 1.01

Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis. Infect Immun (1999) 1.01

Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis. Vet Immunol Immunopathol (2004) 0.98

Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs. Vaccine (2005) 0.89

Class II genes of miniature swine. II. Molecular identification and characterization of B (beta) genes from the SLAc haplotype. Immunogenetics (1990) 0.85

T-helper cell-response to MHC class II-binding peptides of the renal cell carcinoma-associated antigen RAGE-1. Immunobiology (2001) 0.85

Antibody responses to the host-protective Taenia solium oncosphere protein TSOL18 in pigs are directed against conformational epitopes. Parasite Immunol (2010) 0.83

TSOL18/HP6-Tsol, an immunogenic Taenia solium oncospheral adhesion protein and potential protective antigen. Parasitol Res (2008) 0.81

Articles by these authors

Multiple norovirus infections in a birth cohort in a Peruvian Periurban community. Clin Infect Dis (2013) 2.37

Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. J Infect Dis (2007) 2.33

The detection of airborne transmission of tuberculosis from HIV-infected patients, using an in vivo air sampling model. Clin Infect Dis (2007) 2.28

The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med (2008) 2.08

Handheld computers for self-administered sensitive data collection: a comparative study in Peru. BMC Med Inform Decis Mak (2008) 1.82

Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission. PLoS Med (2009) 1.64

Improved detection of Mycobacterium tuberculosis in Peruvian children by use of a heminested IS6110 polymerase chain reaction assay. Clin Infect Dis (2002) 1.56

Thyroid hormone levels improve the prediction of mortality among patients admitted to the intensive care unit. Intensive Care Med (2005) 1.55

Utility of a protein fraction with cathepsin L-Like activity purified from cysticercus fluid of Taenia solium in the diagnosis of human cysticercosis. Am J Trop Med Hyg (2009) 1.53

Genetic diversity and transmission characteristics of Beijing family strains of Mycobacterium tuberculosis in Peru. PLoS One (2012) 1.20

Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990-2011. PLoS One (2013) 1.16

Development of low-cost inverted microscope to detect early growth of Mycobacterium tuberculosis in MODS culture. PLoS One (2010) 1.15

Evaluation of molecular tools for detection and drug susceptibility testing of Mycobacterium tuberculosis in stool specimens from patients with pulmonary tuberculosis. J Clin Microbiol (2010) 1.11

Distinctiveness of Mycobacterium tuberculosis genotypes from human immunodeficiency virus type 1-seropositive and -seronegative patients in Lima, Peru. J Clin Microbiol (2003) 1.08

Taenia solium oncosphere antigens induce immunity in pigs against experimental cysticercosis. Vet Parasitol (2002) 1.07

Diagnosis of pediatric pulmonary tuberculosis by stool PCR. Am J Trop Med Hyg (2008) 1.06

Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones. J Med Chem (2008) 1.06

[Strengthening global health informatics research within the andean region through international collaboration]. Rev Peru Med Exp Salud Publica (2010) 1.05

Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance. Tuberculosis (Edinb) (2011) 1.05

An objective procedure for ischemic area evaluation of the stroke intraluminal thread model in the mouse and rat. J Neurosci Methods (2002) 1.01

SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness. J Neurovirol (2006) 1.00

Genetic diversity of Mycobacterium tuberculosis in Peru and exploration of phylogenetic associations with drug resistance. PLoS One (2013) 0.98

Mortality impact of extreme winter temperatures. Int J Biometeorol (2004) 0.98

Limited diversity of Anopheles darlingi in the Peruvian Amazon region of Iquitos. Am J Trop Med Hyg (2006) 0.96

Campylobacter transmission in a Peruvian shantytown: a longitudinal study using strain typing of campylobacter isolates from chickens and humans in household clusters. J Infect Dis (2003) 0.94

Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance. Infect Genet Evol (2009) 0.93

DNA-level diversity and relatedness of Helicobacter pylori strains in shantytown families in Peru and transmission in a developing-country setting. J Clin Microbiol (2008) 0.93

pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb) (2013) 0.90

High degree of Plasmodium vivax diversity in the Peruvian Amazon demonstrated by tandem repeat polymorphism analysis. Am J Trop Med Hyg (2012) 0.89

Comparison of the peptidase activity in the oncosphere excretory/secretory products of Taenia solium and Taenia saginata. J Parasitol (2007) 0.88

Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis. Bioinformation (2011) 0.86

Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships. Exp Parasitol (2011) 0.86

Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions. PLoS Negl Trop Dis (2012) 0.86

An intervention-control study of corralling of free-ranging chickens to control Campylobacter infections among children in a Peruvian periurban shantytown. Am J Trop Med Hyg (2006) 0.86

A new approach for pyrazinamide susceptibility testing in Mycobacterium tuberculosis. Microb Drug Resist (2012) 0.84

Evaluation of bleach-sedimentation for sterilising and concentrating Mycobacterium tuberculosis in sputum specimens. BMC Infect Dis (2011) 0.84

Docking and quantitative structure-activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitors. J Comput Aided Mol Des (2011) 0.82

Outside-binding site mutations modify the active site's shapes in neuraminidase from influenza A H1N1. Biopolymers (2013) 0.82

Risk factors for canine echinococcosis in an endemic area of Peru. Vet Parasitol (2005) 0.82

Genome sequence and comparative analysis of Avibacterium paragallinarum. Bioinformation (2013) 0.81

Role of metal ions on the activity of Mycobacterium tuberculosis pyrazinamidase. Am J Trop Med Hyg (2012) 0.80

The in vivo antimalarial activity of methylene blue combined with pyrimethamine, chloroquine and quinine. Mem Inst Oswaldo Cruz (2012) 0.80

An atypical age-specific pattern of hepatocellular carcinoma in Peru: a threat for Andean populations. PLoS One (2013) 0.80

Epidemiological study of paracoccidioidomycosis and histoplasmosis in a suburb of San Félix city, Bolívar state, Venezuela. Invest Clin (2009) 0.80

Training the biomedical informatics workforce in Latin America: results of a needs assessment. BMJ Open (2011) 0.80

The Entamoeba histolytica EhPgp5 (MDR-like) protein induces swelling of the trophozoites and alters chloride-dependent currents in Xenopus laevis oocytes. Microb Drug Resist (2002) 0.79

Surveillance for early silicosis in high altitude miners using pulse oximetry. Int J Occup Environ Health (2008) 0.79

Theoretical analysis of the neuraminidase epitope of the Mexican A H1N1 influenza strain, and experimental studies on its interaction with rabbit and human hosts. Immunol Res (2013) 0.78

Trypanocidal properties, structure-activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives. Exp Parasitol (2011) 0.78

New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities. Bioorg Med Chem Lett (2011) 0.78

Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates. PLoS Negl Trop Dis (2011) 0.78

TsAg5, a Taenia solium cysticercus protein with a marginal trypsin-like activity in the diagnosis of human neurocysticercosis. Mol Biochem Parasitol (2011) 0.77

Trypanoside, anti-tuberculosis, leishmanicidal, and cytotoxic activities of tetrahydrobenzothienopyrimidines. Bioorg Med Chem (2010) 0.77

Specific detection and identification of African trypanosomes in bovine peripheral blood by means of a PCR-ELISA assay. Vet Parasitol (2009) 0.76

Field evaluation of a coproantigen enzyme-linked immunosorbent assay for diagnosis of canine echinococcosis in a rural Andean village in Peru. Vet Parasitol (2003) 0.76

Metal-ion effects on the polarization of metal-bound water and infrared vibrational modes of the coordinated metal center of Mycobacterium tuberculosis pyrazinamidase via quantum mechanical calculations. J Phys Chem B (2014) 0.75

Molecular distribution of amino acid substitutions on neuraminidase from the 2009 (H1N1) human influenza pandemic virus. Bioinformation (2013) 0.75

The highly antigenic 53/25 kDa Taenia solium protein fraction with cathepsin-L like activity is present in the oncosphere/cysticercus and induces non-protective IgG antibodies in pigs. Vet Immunol Immunopathol (2011) 0.75

[Cathepsin L cysteine protease from Taenia solium: its biological role in the infection and potential use for the immunodiagnosis of neurocysticercosis]. Rev Peru Med Exp Salud Publica (2013) 0.75

New vaccines needed for pathogens infecting animals and humans: One Health. Hum Vaccin Immunother (2012) 0.75

[Multiple drug resistance in Entamoeba histolytica]. Rev Invest Clin (2002) 0.75

Automatic pneumonia detection based on ultrasound video analysis. Conf Proc IEEE Eng Med Biol Soc (2016) 0.75